Results 261 to 270 of about 73,607 (303)
Sorghum Promotes Cell Proliferation Through Activation of the Growth Hormone/IGF-1-JAK2/STAT5b Signaling Axis <i>In Vitro</i>. [PDF]
Park S +6 more
europepmc +1 more source
Aging changes the mechanism that underlies JAK2 modulation of neutrophil function. [PDF]
Feldmann JW +6 more
europepmc +1 more source
Development Trends of Janus Kinase Inhibitors (JAKi) Over Three Decades: From Common to Rare Diseases. [PDF]
Dai R, Lou N, Zheng X, Han X.
europepmc +1 more source
Polycythemia Vera with Incidental Large Aortic Aneurysm and Giant Cell Arteritis: Case Report. [PDF]
Obaid K +8 more
europepmc +1 more source
Toward new therapy end points in polycythemia vera: targeting clonal and inflammatory pathways. [PDF]
Barbui T, Scandura JM.
europepmc +1 more source
American Journal of Hematology, Volume 101, Issue 6, Page 1196-1200, June 2026.
Bo A. Wan +7 more
wiley +1 more source
JAK2, the JAK2 V617F mutant and cytokine receptors
Recently, a unique recurrent somatic mutation was identified as a major molecular event in polycythemia vera, essential thrombocythemia and idiopathic myelofibrosis. Expression of this mutant in cytokine-dependent hematopoietic cell lines induces autonomous growth. This effect is enhanced by overexpression of cytokine receptors, and can be inhibited by
J, Staerk +7 more
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
JAK2-mediated Intracellular Signaling
Current Molecular Medicine, 2021Janus kinase-2 (JAK2) is a non-receptor tyrosine kinase that serves key roles as the intracellular signaling effector of the cytokine receptor, such as mediating effects of leptin, erythropoietin, interferon, and growth hormone. A lot of molecular underlying mechanisms of JAK2 participation are known, however, additional signaling mechanisms of its ...
Mentor Sopjani +2 more
exaly +3 more sources

